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Summary
Background Data for the causes of maternal deaths are needed to inform policies to improve maternal health. 
We developed and analysed global, regional, and subregional estimates of the causes of maternal death during 
2003–09, with a novel method, updating the previous WHO systematic review.
Methods We searched specialised and general bibliographic databases for articles published between between Jan 1, 
2003, and Dec 31, 2012, for research data, with no language restrictions, and the WHO mortality database for vital 
registration data. On the basis of prespeciﬁ ed inclusion criteria, we analysed causes of maternal death from datasets. 
We aggregated country level estimates to report estimates of causes of death by Millennium Development Goal 
regions and worldwide, for main and subcauses of death categories with a Bayesian hierarchical model. 
 Findings We identiﬁ ed 23 eligible studies (published 2003–12). We included 417 datasets from 115 countries 
comprising 60 799 deaths in the analysis. About 73% (1 771 000 of 2 443 000) of all maternal deaths between 2003 and 
2009 were due to direct obstetric causes and deaths due to indirect causes accounted for 27·5% (672 000, 95% UI 
19·7–37·5) of all deaths. Haemorrhage accounted for 27·1% (661 000, 19·9–36·2), hypertensive disorders 14·0% 
(343 000, 11·1–17·4), and sepsis 10·7% (261 000, 5·9–18·6) of maternal deaths. The rest of deaths were due to abortion 
(7·9% [193 000], 4·7–13·2), embolism (3·2% [78 000], 1·8–5·5), and all other direct causes of death (9·6% [235 000], 
6·5–14·3). Regional estimates varied substantially.
Interpretation Between 2003 and 2009, haemorrhage, hypertensive disorders, and sepsis were responsible for more 
than half of maternal deaths worldwide. More than a quarter of deaths were attributable to indirect causes. These 
analyses should inform the prioritisation of health policies, programmes, and funding to reduce maternal deaths at 
regional and global levels. Further eﬀ orts are needed to improve the availability and quality of data related to maternal 
mortality.
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Introduction
An estimated 287 000 maternal deaths occured worldwide 
in 2010, most of which were in low-income and middle-
income countries and were avoidable.1 Reduction of 
maternal mortality has long been a global health priority 
and is a target in the UN Millennium Development Goals 
(MDG) framework2 and a key concern of the Global 
Strategy for Women’s and Children’s Health launched by 
the UN Secretary-General in September, 2010.3 To reach the 
target of the ﬁ fth MDG, a 75% decrease in maternal 
mortality ratio (the number of maternal deaths per 100 000 
livebirths) between 1990 and 2015 is needed. Some progress 
towards this target has been reported, especially in the past 
decade,1,4–6 but further improvements are needed.
A key requirement for further advances in reduction of 
maternal deaths is to understand the causes of deaths for 
eﬀ ective policy and health programme decisions. The 
deﬁ nition of maternal mortality (“the death of a woman 
whilst pregnant or within 42 days of delivery or termination 
of pregnancy, from any cause related to, or aggravated by 
pregnancy or its management, but excluding deaths from 
incidental or accidental causes”7) allows the identiﬁ cation 
of maternal deaths on the basis of their causes, as either 
direct or indirect. However, collection of routine and 
complete information about causes of maternal death has 
not been possible because of inadequacies of data 
collection and absence of vital registration systems in 
most countries. The ﬁ rst systematic analysis of all available 
published scientiﬁ c literature and government reports on 
causes of maternal death was published in 2006, and 
provided an overall picture of the contribution of diﬀ erent 
causes to the burden of maternal deaths. In 2006, we 
reported haemorrhage and hypertensive disorders as the 
leading causes of maternal mortality in developing 
regions.8 More recently, the Global Burden of Disease 
(GBD) study9 provided estimates of maternal causes of 
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death for the main direct causes as part of the analysis of 
all causes of death.
We analysed global, regional, and subregional estimates 
of the causes of maternal death during 2003–09, with a 
novel method. This period was chosen to avoid overlap 
with the previous review that covered 1998–2002.8 The 
study period did not include reported deaths from more 
recent years to ensure increased comparability across 
countries; more recent data were not available for most 
countries, especially within the WHO mortality database 
that includes vital registration datasets made available by 
the countries. We also elaborated for the ﬁ rst time further 
breakdown of main cause of death categories, and provided 
cause of death estimates for disorders that are clinically 
important—eg, antepartum and postpartum haemorrhage.
Methods
Search strategy and selection criteria
We used the International Classiﬁ cation of Diseases 
(ICD, 10th edition) deﬁ nition of maternal mortality,7 and 
included maternal deaths reported during 2003–09, and 
generated regional estimates for the ten MDG regions.10 
We searched for data for causes of maternal death from 
two distinct sources. We used vital registration datasets 
from the WHO mortality database, made available by 
countries.11 We deemed vital registration data as good 
quality if the completeness of death registration in the 
population older than 5 years was more than 85% and 
the proportion of ill-deﬁ ned causes of death (coded as 
R99) were less than 20%. Details of how we assessed 
completeness and coverage of vital registration data by 
WHO mortality statistics are described elsewhere.1
We also did a literature search of bibliographic 
databases by adapting a previously described search 
strategy12 (appendix). Two reviewers (ABM and DC) 
initially screened the citations identiﬁ ed by the searches 
on the basis of their titles and abstracts. The full text of 
the article was obtained if both reviewers judged a 
citation as potentially eligible and a third reviewer (JPD) 
adjudicated on discrepant opinions. A second round of 
screening of the full reports was done in the same way. 
Additionally, we identiﬁ ed government reports including 
cause-of-death information by hand searching WHO 
regional databases, websites of Ministries of Health and 
National Statistical Oﬃ  ces, and archives of relevant 
reports received by WHO. We considered studies 
identiﬁ ed through the literature search and governmental 
reports for inclusion if they reported data for the causes 
of maternal mortality between Jan 1, 2003, and Dec 31, 
2009. We excluded studies that contained data before 
2003 that could not be dis aggregated from after 2002 
data and with midpoint of the data collection period 
before 2003. In line with the 2006 review, we also 
excluded studies reporting fewer than 25 deaths or fewer 
than four major categories of death.8 Lastly, we excluded 
studies in which more than 25% of deaths did not have a 
cause assigned. We considered subnational studies for 
inclusion only if investigators explicitly reported 
methods and if the maternal deaths that they reported 
were deemed to be representative of the population they 
pertained to. We included studies from health facilities 
or institutions only if the institutional birth rate was 
greater than or equal to 50% in that setting during 
2003–09. The institutional birth rate was based on the 
national country reported ﬁ gure derived from sources 
such as Demographic and Health Surveys, Multiple 
Indicator Cluster Surveys, and national health statistical 
reports.
If diﬀ erent data sources overlapped for a country 
period, we included only one data source, and national 
data took precedence over data from subnational levels in 
the following order: national enquiries, vital registration, 
and nationally representative surveys of maternal deaths. 
Thus, although countries might have had only one 
source of data for any particular year, more than one 
source might have been included in the entire study 
period 2003–09.
Data extraction and classiﬁ cation of maternal deaths
Data extraction from studies and reports was done by one 
reviewer (ABM) and independently checked on the form 
by another (JPD or DC). ICD-10 codes were used to classify 
causes of maternal death (appendix). Data using ICD-9 
codes were converted to ICD-10 codes with the WHO 
ICD-10 Translator.13 We excluded vital registration data 
from Russia, Kazakhstan, Belarus, and Ukraine reported 
with ICD 10-1 because accurate assignment of deaths to 
the equivalent ICD-10 codes or analytical pregnancy or 
obstetric categories was not possible. We assigned 
See Online for appendix
Figure 1: Study proﬁ le
338 datapoints from 79 
countries (vital registration)
56 datapoints from 32 
countries (government 
reports, special surveys, 
and confidential enquiries)
Bibliographic databases
23 datapoints from 11 countries
11 051 citations (2003–08)
435 titles for review
14 853 citations (2008–10)
220 titles for review
24 275 citations (2010–12)
222 titles for review
62 378 deaths reported in 417 datapoints from 115 countries
60 799 deaths reported in 417 datapoints from 115 countries
1579 deaths excluded because of 
unascertained cause of death
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research study data equivalent ICD-10 codes by matching 
the closest diagnosis. When data presented were 
ambiguous, contradictory, or could not be disaggregated, 
we tried to contact the author for clariﬁ cation. If this was 
not successful, we used the consensus view of two of the 
authors (JPD, DC). Maternal deaths assigned to unknown 
as a cause of death were excluded from the analysis.
For analysis purposes, we grouped maternal causes of 
death into seven main categories of direct and indirect 
causes: abortion, embolism, obstetric haemorrhage, 
hypertensive disorders, pregnancy-related sepsis, other 
direct causes, and indirect causes. The abortion category 
includes induced abortion, miscarriage, and ectopic 
pregnancy. We deﬁ ned the category of indirect maternal 
deaths in line with the WHO application of ICD-10 
(ICD-MM) to deaths during pregnancy, childbirth, and the 
puerperium.14 ICD-MM was published to enable a 
standardised grouping of causes of death and to avoid 
presentation of highly aggregated data in diﬀ ering 
classiﬁ cation groups, complicating the task of data 
comparability. The broad ICD-MM categories were further 
subdivided. The category haemorrhage was divided into 
subcategories of antenatal, intrapartum, and postpartum 
haemorrhage; other direct causes were subcategorised into 
complications of delivery, obstructed labour, and all other 
direct causes. Indirect causes of death were subcategorised 
into medical disorders, HIV-related maternal deaths, and 
all other indirect causes.
Statistical analysis
For every country, we estimated the causes of death 
distribution on the basis of country-speciﬁ c data (if 
available) and the regional causes of death distribution 
with a Bayesian hierarchical model. We estimated all 
causes and subcauses hierarchically except for the 
proportion of HIV/AIDS indirect deaths, which we 
modelled separately because of the dependence of the 
proportion on the severity of the HIV/AIDS epidemic in 
the country.
To construct country-speciﬁ c HIV/AIDS-removed causes 
of death distribution, we divided countries into three 
categories on the basis of data availability and data quality. 
We divided countries with recorded causes of death 
distribution into categories A and B, and combined 
countries without any data in group C.15 Category A 
included all countries with good quality and complete vital 
registration data, where the sample of maternal deaths (for 
which the recorded causes of death distribution was 
obtained) was deemed to be representative of the total 
number of maternal deaths for the country during the 
period of interest. For countries in category B for which 
vital registration data might have been available but not 
considered good quality, we assumed that the estimated 
causes of death distribution from the recorded samples 
were not necessarily representative of the causes of death 
distribution of all maternal deaths in the period of interest 
(appendix p 7).
Figure 2: Estimates for main causes of death worldwide
Point estimates are shown by bars (and squares) and 95% uncertainty 
intervals are shown by the horizontal lines. CoDD=cause of death distribution. 
ABO=abortion. EMB=embolism. HEM=haemorrhage. HYP=hypertension. 
SEP=sepsis. DIR=direct causes. IND=indirect causes. Dev=developed regions. 
N Africa=northern Africa. SSA=sub-Saharan Africa. E Asia=eastern Asia. 
S Asia=southern Asia. SE Asia=southeastern Asia. W Asia=western Asia. 
CC Asia=Caucasus and central Asia. LAC=Latin America and the Caribbean.
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We used the Bayesian hierarchical model for the HIV/
AIDS-removed cause of death distribution to exchange 
information about these distributions between countries. 
With this method, the estimates in countries with scarce 
information were informed by the typical experience in 
the region, which is the HIV/AIDS-removed causes of 
death distribution that is unweighted by the country-
speciﬁ c total maternal deaths envelopes in the region. 
Additionally, in the hierarchical model, typical regional 
patterns in groups with scarce information were informed 
by patterns in other regions. For countries in group C, the 
cause of death distribution estimates were given by the 
typical regional estimates, and we assessed uncertainty on 
the basis of the estimated variability in, and correlation 
structure of, country-speciﬁ c causes of death distribution 
within regions. For countries in group A with good quality 
vital registration data, the cause of death distribution was 
estimated from the recorded causes of death distribution, 
accounting for stochastic uncertainty—ie, uncertainty that 
arises when dealing with small numbers of observed 
deaths. For example, if only ﬁ ve deaths were recorded in a 
country, the underlying true cause of death distribution is 
uncertain. The extent of uncertainty in cause of death 
distribution for group A countries ranged from being 
negligible for countries where a large number of deaths 
were observed to substantial uncertainty for countries 
where causes of death for only a small number of deaths 
were recorded (eg, Belgium, where the causes of deaths 
for only ﬁ ve maternal deaths were recorded). For countries 
with substantial uncertainty on the basis of a small 
number of deaths, the hierarchical model informed the 
country-speciﬁ c estimate, whereas for countries with less 
uncertainty, estimates were more data-driven and less 
informed by the hierarchical model. For countries in 
category B (where the recorded cause of death distributions 
were available for a subset of maternal deaths from vital 
registration or survey data), we assumed that the estimated 
causes of death distributions from the recorded samples 
were not necessarily representative of the causes of death 
distributions of all maternal deaths in the period of 
interest. For these countries, we assessed uncertainty in 
the cause of death distribution estimates for all maternal 
deaths without recorded causes on the basis of estimated 
variability in, and correlation structure of, country-speciﬁ c 
cause of death distributions within regions. Therefore, the 
ﬁ nal estimated cause of death distributions for countries 
in group B accounted for stochastic uncertainty and 
additional uncertainty in the cause of death distributions 
for the unrecorded subset of maternal deaths.
The estimation of the proportion of HIV/AIDS 
maternal deaths was based on the approach used in the 
estimation of the total number of maternal deaths.1,16 
This approach provides country-speciﬁ c estimates for the 
proportion of HIV/AIDS maternal deaths among all 
AIDS deaths to women of reproductive ages. These 
country-speciﬁ c estimates were combined with estimates 
Abortion Embolism Haemorrhage Hypertension Sepsis Other direct causes Indirect causes
N % (95% UI) N % (95% UI) N % (95% UI) N % (95% UI) N % (95% UI) N % (95% UI) N % (95% UI)
Worldwide 193 000 7·9%
(4·7–13·2)
78 000 3·2%
(1·8–5·5)
661 000 27·1%
(19·9–36·2)
343 000 14·0%
(11·1–17·4)
261 000 10·7%
(5·9–18·6)
235 000 9·6%
(6·5–14·3)
672 000 27·5%
(19·7–37·5)
Developed regions 1100 7·5%
(5·7–11·6)
2000 13·8%
(10·1–22·0)
2400 16·3
(11·1–24·6)
1900 12·9%
(10·0–16·8)
690 4·7%
(2·4–11·1)
2900 20·0%
(16·6–27·5)
3600 24·7%
(19·5–33·9)
Developing regions 192 000 7·9%
(4·7–13·2)
76 000 3·1%
(1·7–5·4)
659 000 27·1%
(19·9–36·4)
341 000 14·0%
(11·1–17·4)
260 000 10·7%
(5·9–18·7)
232 000 9·6%
(6·4–14·3)
668 000 27·5%
(19·7–37·6)
Northern Africa 490 2·2%
(0·9–4·9)
720 3·2%
(0·9–8·9)
8300 36·9%
(24·1–51·6)
3800 16·9%
(11·9–22·9)
1300 5·8%
(2·3–12·9)
3800 17·1%
(7·7–30·8)
4000 18·0%
(9·5–30·2)
Sub-Saharan Africa 125 000 9·6%
(5·1–17·2)
27 000 2·1%
(0·8–4·5)
321 000 24·5%
(16·9–34·1)
209 000 16·0%
(11·7–21)
134 000 10·3%
(5·5–18·5)
119 000 9·0%
(5·1–15·7)
375 000 28·6%
(19·9–40·3)
Eastern Asia 420 0·8%
(0·2–2·0)
6500 11·5%
(1·6–40·6)
20 000 35·8%
(10·9–68·2)
5900 10·4%
(3·9–20·2)
1500 2·6%
(0·4–9·7)
8000 14·1%
(2·0–51·3)
14 000 24·9%
(6·4–58·8)
Southern Asia 47 000 5·9%
(1·5–17·3)
17 000 2·2%
(0·5–6·8)
238 000 30·3%
(14·0–54·8)
80 000 10·3%
(5·8–16·6)
107 000 13·7%
(3·3–35·9)
65 000 8·3%
(3·3–17·7)
229 000 29·3%
(12·2–55·1)
Southeastern Asia 11 000 7·4%
(2·8–18·4)
18 000 12·1%
(3·2–33·4)
44 000 29·9%
(15·2–51·3)
21 000 14·5%
(8·4–22·7)
8100 5·5%
(1·8–15·0)
20 000 13·8%
(5·6–31·2)
25 000 16·8%
(7·8–34·2)
Western Asia 860 3·0%
(1·0–7·6)
2600 9·2%
(3·3–22·6)
8900 30·7%
(17·4–49·1)
3900 13·4%
(7·5–21·2)
1400 4·8%
(1·5–13·1)
4500 15·6%
(6·6–33·7)
6700 23·4%
(11·3–43·1)
Caucasus and 
central Asia
250 4·6%
(2·7–8·2)
590 10·9%
(6·2–18·2)
1200 22·8%
(17·2–30·3)
790 14·7%
(11·6–18·3)
460 8·5%
(5·7–13·6)
910 16·8%
(12·6–23·2)
1200 21·8%
(16·2–29·9)
Latin America 
and Caribbean
6900 9·9%
(8·1–13·0)
2300 3·2%
(2·6–4·7)
16 000 23·1%
(19·7–27·8)
15 000 22·1%
(19·9–24·6)
5800 8·3%
(5·6–12·5)
10 000 14·8%
(11·7–19·4)
13 000 18·5%
(15·6–22·6)
Oceania 290 7·1%
(1·2–22·9)
610 14·8%
(1·9–47·6)
1200 29·5%
(8·5–61·7)
560 13·8%
(4·9–25·8)
200 5·0%
(0·6–18·5)
510 12·4%
(2·3–38·7)
710 17·4%
(4·7–44·3)
Data shown are the estimated proportion of cause of death (%) with 95% uncertainty interval (95% UI).
 Table 1: Distribution of causes of deaths by Millennium Development Goal regions
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of the number of AIDS, maternal, and total deaths to 
women of reproductive ages to obtain an initial mean 
estimate for the proportion of HIV/AIDS maternal 
deaths. These estimates were updated with country-
speciﬁ c data on the proportion of HIV/AIDS deaths.
We used a Markov Chain Monte Carlo algorithm to 
generate samples of the posterior distributions of all 
model parameters, including the country-speciﬁ c causes 
of death distributions. Point estimates for proportions 
were given by the posterior means of the proportion and 
95% uncertainty intervals were given by the 2·5th and 
97·5th percentiles of the posterior distributions. We 
calculated the resulting distribution for each region from 
the regional weighted averages of the estimated country-
speciﬁ c cause of death distributions in the region. 
Weights were based on the estimated number of maternal 
deaths for each country for the year 2005 (which is the 
estimation year closest to the midpoint of the study 
period).1 The Markov Chain Monte Carlo sampling 
algorithm was implemented in R (version 3.0.1) and JAGS 
(version 3.3.0).17,18 
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication. 
Results
Figure 1 summarises the identiﬁ cation and selection of 
data for incorporation into the model. We included vital 
registration data from 79 countries, covering 338 country-
year datapoints during 2003–09, of which 263 (78%) came 
from 58 countries with a good quality registration system. 
Of the 50 179 citations identiﬁ ed from bibliographic 
databases, 23 studies from 11 countries met the inclusion 
criteria. Government reports, such as specialised statistical 
tabulations and surveillance documents, were available for 
a further 32 countries. These reports included “conﬁ dential 
enquiries”, ”RAMOS”, or specialised “maternal mortality 
surveys”. Four countries (France, UK, South Africa, and 
Mexico) produced conﬁ dential enquiries or reports of 
enhanced surveillance systems covering 12 country-years, 
which were judged better than vital registration data for 
that country. 26 datasets were informed by verbal autopsy; 
however, only ten of these datasets speciﬁ ed the verbal 
autopsy instrument used. The appendix shows further 
details of source of data by country and the studies 
providing the datasets.
All included data sources combined provided 
417 datapoints from 115 countries and reported 
62 378 deaths. Of these, we excluded 1579 deaths (2·5%), 
almost exclusively from studies and governmental 
reports, because no main cause of death could be 
ascertained (appendix). Of the 60 799 maternal deaths 
included in the ﬁ nal database, 50% came from vital 
registration data, 29% from sub-Saharan Africa, and 2% 
from southern Asia. Considering the total estimated 
number of maternal deaths over 7 years, the study data 
represents 2.5% of all maternal deaths in that period.4
Figure 2 shows the regional and global estimates of 
distribution of causes of death. Nearly 73% of all maternal 
deaths between 2003 and 2009 were due to direct obstetric 
causes whereas deaths due to indirect causes accounted 
for 27·5% (95% UI 19·7–37·5) of all deaths from known 
causes (table 1). Haemorrhage was the leading direct 
cause of maternal death worldwide, representing 27·1% 
(19·9–36·2) of maternal deaths. More than two thirds of 
reported haemorrhage deaths were classiﬁ ed as 
postpartum haemorrhage (table 2). Hypertension was the 
second most common direct cause worldwide (14·0%, 
11·1–17·4). Maternal mortality due to sepsis was 10·7% 
(5·9–18·6), abortion accounted for 7·9% (4·7–13·2), and 
embolism and other direct causes accounted for the 
remaining 12·8% of global deaths.
Table 3 shows the other direct causes of maternal 
mortality. Complications of delivery were responsible 
for 2·8% (1·6–4·9) and obstructed labour for 2·8% 
(1·4–5·5) of all maternal deaths worldwide, both 
reported within the other direct category, which 
accounted for 9·6% of all maternal deaths worldwide. 
Further breakdown of deaths due to indirect causes 
suggests that more than 70% of indirect causes are 
Antepartum Intrapartum Postpartum Haemorrhage total
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
Worldwide 158 000 6·5%
(4·3–9·6)
23 000 0·9%
(0·4–2·2)
480 000 19·7%
(12·9–28·9)
661 000 27·1%
(19·9–36·2)
Developed 
regions
700 4·8%
(3·3–7·9)
510 3·5%
(1·6–11·1)
1200 8·0%
(4·7–15·5)
2400 16·3%
(11·1–24·6)
Developing 
regions
157 000 6·5%
(4·3–9·6)
23 000 0·9%
(0·4–2·2)
479 000 19·7%
(12·9–29)
659 000 27·1%
(19·9–36·4)
Northern 
Africa
720 3·2%
(1·5–6·2)
380 1·7%
(0·3–6·8)
7200 32·0%
(18·9–47·3)
8300 36·9%
(24·1–51·6)
Sub-Saharan 
Africa
110 000 8·4%
(5·0–13·7)
12 000 0·9%
(0·2–3)
200 000 15·2%
(8·6–25·1)
321 000 24·5%
(16·9–34·1)
Eastern Asia 3800 6·6%
(1·6–17·4)
210 0·4%
(0·1–1·7)
16 000 28·7%
(6·1–63·9)
20 000 35·8%
(10·9–68·2)
Southern Asia 30 000 3·8%
(1·5–8·5)
3400 0·4%
(0·1–1·5)
205 000 26·1%
(10·4–51·4)
238 000 30·3%
(14·0–54·8)
Southeastern 
Asia
7000 4·7%
(2·0–10·7)
3100 2·1%
(0·3–8·7)
34 000 23·1%
(9·4–46·1)
44 000 29·9%
(15·2–51·3)
Western Asia 1700 6·0%
(2·9–11·7)
710 2·5%
(0·4–10·4)
6400 22·2%
(10·1–41·5)
8900 30·7%
(17·4–49·1)
Caucasus and 
central Asia
280 5·2%
(3·5–7·9)
230 4·2%
(1·6–10·7)
720 13·4%
(9·4–19·8)
1200 22·8%
(17·2–30·3)
Latin America 
and Caribbean
4000 5·8%
(4·5–7·8)
2900 4·1%
(2·1–9·0)
9200 13·3%
(10·9–16·4)
16 000 23·1%
(19·7–27·8)
Oceania 200 4·8%
(1·0–13·8)
76 1·8%
(0·1–11·3)
940 22·9%
(4·1–57·8)
1200 29·5%
(8·5–61·7)
Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset. 
Table 2: Subgroup analysis of haemorrhage deaths by Millennium Development Goal region
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from pre-existing disorders, including HIV, when 
exacerbated by pregnancy (table 4). HIV alone accounted 
for 5·5% (3·8–7·6) of global maternal deaths.
The global distribution was aﬀ ected by the two regions, 
sub-Saharan Africa and southern Asia, that accounted for 
83·8% of all maternal deaths. Although estimated regional 
cause of death distributions are quite uncertain for many 
causes, point estimates show substantial diﬀ erences 
across regions (table 1 and ﬁ gure 3). Haemorrhage 
accounted for 36·9% (24·1–51·6) of deaths in northern 
Africa, but only for 16·3% (11·1–24·6) in developed 
regions. Hypertensive disorders were a particularly 
important cause of death in Latin American and the 
Caribbean, contributing to 22·1% (19·9–24·6) of all 
maternal deaths in the region. Almost all sepsis deaths 
were recorded in the developing countries, and the 
proportion of such deaths was highest at 13·7% (3·3–35·9) 
in southern Asia.
Only a small proportion of deaths are estimated to 
result from abortion in eastern Asia (0·8%, 0·2–2·0), 
where access to abortion is generally less restricted. Latin 
America and the Caribbean, and sub-Saharan Africa 
have a higher proportion of deaths in this category than 
the global average; 9·9% (8·1–13·0) and 9·6% (5·1–17·2), 
respectively. Another direct cause, embolism, accounted 
for more deaths than its global average in southeastern 
Asia (12·1%, 3·2–33·4) and eastern Asia (11·5%, 1·6–40·6).
The proportion of deaths due to indirect causes was 
highest in southern Asia (29·3%, 12·2–55·1), followed by 
sub-Saharan Africa (28·6%, 19·9–40·3). Indirect causes 
also accounted for nearly a quarter of deaths in the 
developed regions. The overall proportion of HIV 
maternal deaths is highest in sub-Saharan Africa, 6·4% 
(4·6–8·8%). The appendix shows estimates for country-
speciﬁ c cause of death distributions.
Discussion
This systematic analysis suggests that indirect causes and 
haemorrhage are the largest causes of maternal death 
worldwide. Of the direct causes of death, haemorrhage 
was the leading cause of maternal death, followed by 
hypertensive disorders and sepsis. Regional estimates 
varied substantially.
We scanned and included many data sources including 
government reports and peer-reviewed scientiﬁ c 
literature (panel). Because of the paucity of data, all data 
for a country were aggregated during the 7-year period 
and model-based estimates were constructed for the 
large subset of countries without any information about 
their causes of death distributions. This approach diﬀ ers 
from the previous WHO systematic review8 in which 
recorded country-speciﬁ c cause of death distributions 
were weighted by the number of maternal deaths in the 
country to obtain regional estimates. The new approach 
was implemented to overcome the drawback of the 
previous study that a recorded cause of death distribution 
based on a small sample size in a country with a large 
number of maternal deaths could unduly aﬀ ect the 
regional estimates of the cause of death distribution. In 
the estimation method applied in this study, country-
speciﬁ c estimates of cause of death distribution were 
informed by the available data in the country and the 
regional average cause of death distribution, which can 
be regarded as a typical pattern for the region (unweighted 
by the total maternal death envelopes of the countries in 
the region) through a Bayesian hierarchical model. The 
accuracy of the regional and global estimates and 95% 
uncertainty intervals were validated through two out-of-
sample validation exercises and suggested satisfactory 
model performance (appendix).
The diﬀ erent analytical approaches of the previous 
WHO review published in 2006 and the present analysis 
limit our ability to make comparisons between the 
ﬁ ndings of both. Furthermore, the limitations of the 
dataset and the methods used in the previous study did 
not allow for generation of a worldwide cause-of-death 
estimate, and only estimates for large world regions were 
calculated. However, some of the region-speciﬁ c trends 
reported in the previous analysis also seem to be found 
in the present study. These include, for example, the 
highest share of haemorrhage deaths in Asian regions, 
the particular importance of hypertensive disorders of 
pregnancy in Latin America and the Caribbean, and the 
importance of indirect causes in sub-Saharan Africa.
Complications 
of delivery
Obstructed labour Other Other direct 
causes total
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
Worldwide 68 000 2·8
(1·6–4·9)
69 000 2·8
(1·4–5·5)
98 000 4
(2·2–7·5)
235 000 9·6
(6·5–14·3)
Developed 
regions
760 5·2
(3·7–9·0)
94 0·6
(0·3–1·7)
2100 14·1
(11·8–20·9)
2900 20
(16·6–27·5)
Developing 
regions
67 000 2·8
(1·5–4·9)
69 000 2·9
(1·4–5·5)
96 000 3·9
(2·1–7·4)
232 000 9·6
(6·4–14·3)
Northern 
Africa
1600 7·3
(2·9–15·9)
210 0·9
(0·2–3·3)
2000 8·8
(2·6–20·9)
3800 17·1
(7·7–30·8)
Sub-Saharan 
Africa
43 000 3·3
(1·5–6·7)
28 000 2·1
(0·7–5·2)
48 000 3·7
(1·4–8·6)
119 000 9
(5·1–15·7)
Eastern Asia 250 0·4
(0·1–1·4)
6900 12·3
(0·9–50·1)
770 1·4
(0·2–5·8)
8000 14·1
(2–51·3)
Southern Asia 14 000 1·8
(0·4–5·2)
21 000 2·7
(0·5–8·5)
30 000 3·8
(0·9–10·3)
65 000 8·3
(3·3–17·7)
Southeastern 
Asia
3000 2·1
(0·5–6·6)
9400 6·4
(1·4–20·6)
7800 5·3
(1·3–17·3)
20 000 13·8
(5·6–31·2)
Western Asia 2000 7·1
(2·4–17·9)
320 1·1
(0·2–4·2)
2200 7·5
(2–23·2)
4500 15·6
(6·6–33·7)
Caucasus and 
central Asia
400 7·3
(5·2–10·9)
47 0·9
(0·4–1·9)
460 8·6
(5·6–14·4)
910 16·8
(12·6–23·2)
Latin America 
and Caribbean
2300 3·3
(2·6–4·9)
3300 4·8
(3·2–8·3)
4700 6·7
(4·8–10·3)
10 000 14·8
(11·7–19·4)
Oceania 95 2·3
(0·3–8·9)
210 5·1
(0·3–25·5)
210 5·1
(0·4–23·5)
510 12·4
(2·3–38·7)
Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset.
Table 3: Subgroup analysis of other direct causes of death by Millennium Development Goal region
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Ultimately, the results of this analysis are constrained 
by the accuracy of the data included. Cause of death data 
are especially diﬃ  cult to analyse because of inadvertent 
errors such as misclassiﬁ cation and misinterpretation of 
cause of death coding rules, or omissions or incorrect 
entries because of the nature of some of the disorders 
leading to maternal deaths such as abortion. We 
recognise the limitations due to the particular issue of 
misclassiﬁ cation within maternal death certiﬁ cation.
Although algorithms have been developed to adjust for 
misclassiﬁ cation of deaths in so-called garbage codes,32 
such algorithms are not able to improve on misclassiﬁ cation 
within maternal cause categories or the under-reporting of 
deaths of speciﬁ c maternal causes. In view of the range of 
classiﬁ cation and under-reporting issues, and the limited 
information available to accurately adjust data, we opted to 
report aggregated cause of death fractions as reported in 
good vital registration or as predicted by the model based 
on unadjusted data. Therefore, resulting estimates should 
be interpreted as the estimates for the reported cause of 
death distribution.
An alternative estimation method was used more 
recently in the GBD Study 2010 to obtain estimates for 
the all-cause cause of death distribution, whereby a subset 
of misclassiﬁ cation issues were accounted for.9,33 The 
GBD broad categorisation of causes of maternal death 
diﬀ ered from our approach, with important diﬀ erences 
for some categories. For example, the GBD did not use a 
category of indirect causes. Likewise, we included 
obstructed labour as a subcategory of other direct causes, 
in line with the ICD-MM, whereas the GBD study 
regarded it as a main category.9 Inclusion of various 
disorders within identiﬁ ed categories also diﬀ ered. For 
example, long labour is included in the obstructed labour 
category in our analysis, but not in the GBD study. 
Nevertheless, broad agreement exists between our global 
estimates and the GBD estimates (appendix).
However, estimates on maternal causes of death should 
be viewed with caution. Although future research on 
improved modelling approaches to deal with mis-
classiﬁ cation errors might lead to improved estimates, 
the absence of reliable data is a more pressing issue that 
demands increased prioritisation.
Recommendations for policy and practice
Our results show two main concerns for policy and 
practice related to data availability and quality in the 
countries. First, where data are most needed, data are 
often not available, which is unfortunately the case in 
some countries with high mortality where estimates 
were obtained on the basis of modelling. In this 
analysis, India and Nigeria together accounted for a 
third of global maternal deaths, but only one dataset 
met criteria for inclusion (India). Of the ten countries 
with the highest maternal mortality ratio in 2010, data 
were available only for one, Cameroon. Moreover, only 
5% of all deaths included in the analysis were from 
southern Asia where the second highest number of 
maternal deaths were recorded. This means that cause 
of death distribution in a region is aﬀ ected by the 
countries that have data within that region. Although 
the distribution is expected to be similar across 
countries within a region, for some conditions where 
availability of interventions signiﬁ cantly vary because 
of structural factors that are also highly contextual, 
such as the legal status of abortion, diﬀ erences are 
expected.
Second, where data are available, they are often 
incomplete. For example, we noted that indirect deaths 
accounted for 27·5% (19·7–37·5) of deaths, although 
the actual indirect causes were not well delineated in 
more than a ﬁ fth of the reported indirect maternal 
deaths. Although it might be diﬃ  cult to establish with 
certainty whether a woman’s pregnancy aggravated a 
pre-existing medical disorder, or if their interaction 
resulted in her death, improved documentation on the 
sequence of events is paramount. For instance, 
diﬀ erentiation between indirect maternal deaths due to 
HIV and direct maternal deaths in HIV-positive women 
is important; this diﬀ erence would have implications at 
both clinical and programmatic levels. Accelerated 
action is needed to improve data acquisition and quality, 
especially relating to correct attribution of cause of 
death information.
HIV-related Pre-existing medical 
conditions
Other indirect 
causes
Indirect causes
total
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
N %
(95% UI)
Worldwide 134 000 5·5%
(3·8–7·6)
361 000 14·8
(9·2–23·4)
177 000 7·2%
(3·5–14·6)
672 000 27·5%
(19·7–37·5)
Developed 
regions
400 2·7%
(1·0–5·1)
3000 20·3
(16·1–29·1)
250 1·7%
(0·9–4·4)
3600 24·7%
(19·5–33·9)
Developing 
regions
133 000 5·5%
(3·8–7·7)
358 000 14·8
(9·1–23·5)
177 000 7·3%
(3·5–14·7)
668 000 27·5%
(19·7–37·6)
Northern 
Africa
760 3·4%
(1·1–6·4)
2800 12·4
(5·3–24·1)
500 2·2%
(0·6–7·2)
4000 18·0%
(9·5–30·2)
Sub-Saharan 
Africa
84 000 6·4%
(4·6–8·8)
168 000 12·8
(7·0–22·3)
122 000 9·3%
(4·6–18·4)
375 000 28·6%
(19·9–40·3)
Eastern
Asia
2200 3·9%
(0·3–10·6)
12 000 20·7
(3·5–54·4)
130 0·2%
(0·0–1·1)
14 000 24·9%
(6·4–58·8)
Southern Asia 37 000 4·8%
(1·2–10·2)
143 000 18·2
(6·1–41·9)
49 000 6·3%
(0·5–25·3)
229 000 29·3%
(12·2–55·1)
Southeastern 
Asia
5900 4·0%
(1·4–8·3)
17 000 11·8
(4·1–28·7)
1400 1·0%
(0·2–3·5)
25 000 16·8%
(7·8–34·2)
Western Asia 1200 4·2%
(1·5–8·4)
4900 16·9
(6·5–36·5)
650 2·2%
(0·5–8·1)
6700 23·4%
(11·3–43·1)
Caucasus and 
Central Asia
130 2·3%
(1·0–4·1)
920 16·9
(11·9–24·7)
140 2·5%
(1·4–5·1)
1200 21·8%
(16·2–29·9)
Latin America 
and Caribbean
1300 1·8%
(0·9–3·0)
9800 14·0
(11·7–17·6)
1800 2·6%
(1·9–4·5)
13 000 18·5%
(15·6–22·6)
Oceania 170 4·2%
(0·5–11·1)
500 12·3%
 (1·9–38·2)
36 0·9%
(0·1–4·4)
710 17·4%
(4·7–44·3)
Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset.
 Table 4: Subgroup analysis of indirect causes of death by Millennium Development Goal region
Articles
e330 www.thelancet.com/lancetgh    Vol 2   June 2014
We included several sources of cause of death data, the 
quality of which depends on who completed the death 
certiﬁ cate or verbal autopsy, who interpreted the 
information from the death certiﬁ cate or verbal autopsy, 
and whether medical records were available for review to 
conﬁ rm or revise the ascertained cause of death. 
Conﬁ dential enquires and special maternal death reviews 
can provide such information, but the feasibility of doing 
such detailed reviews is very restricted.
To support data acquisition and quality needs, revisions 
are being made to the standard verbal autopsy instrument 
to increase the feasibility of its implementation where 
cause of death attribution is possible only by those 
means. Furthermore, the ICD-MM will standardise 
documentation and analysis related to maternal causes 
of death and their attribution to direct and indirect 
causes.14 Discrepancies exist in how some deaths are 
categorised. For example, suicide in some contexts is 
regarded as coincidental whereas in other settings it 
might be reported within direct or indirect maternal 
deaths. Maternal suicides are known to happen in the 
context of undesired pregnancy, inability to access 
abortion, and postpartum depression or psychosis. ICD-
MM suggests that maternal suicides will be included 
within the direct category of maternal death. With the 
process for the 11th revision of the ICD well underway,34 
one can anticipate the possibility for improved granularity 
of data. But one must also recognise the responsibility of 
the certifying professional to provide accurate and useful 
information for improved epidemiological monitoring 
and assessment to inform policies with the best available 
evidence. Calls for inclusion of training on cause of death 
certiﬁ cation and the use of ICD use within medical 
curricula are well founded and should be supported. 
Still, these calls for better data need to acknowledge the 
realities in establishing, with accuracy, what the cause of 
death was at time of certiﬁ cation. This need for accuracy 
is especially important in relation to identiﬁ cation of 
indirect maternal deaths that aim to establish the 
aggravating eﬀ ect between the physiological eﬀ ects of 
pregnancy and another disease.
With regard to clinical implications, we ﬁ nd that, despite 
established interventions to prevent and treat postpartum 
haemorrhage (eg, active management of the third stage of 
labour35), haemorrhage remains the leading individual 
cause of death. With available data, it is not possible to 
establish whether the persistence of haemorrhage as the 
leading cause of death despite eﬀ ective interventions is 
the result of a failure to implement such interventions, 
whether there is a shift towards antepartum haemorrhage 
or a shift in delivery practice such as increasing rates of 
caesarean sections, or whether misclassiﬁ cations with 
regard to abortion and obstructed labour are erroneously 
increasing the haemorrhage category.
Further analysis to elucidate the separate contribution of 
antepartum and postpartum causes will have important 
implications for the planning and implementation of policy 
Figure 3: Estimates for main causes of death by region
Point estimates are shown by bars (and squares) and 95% uncertainty intervals 
are shown by the horizontal lines. ABO=abortion. EMB=embolism. 
HEM=haemorrhage. HYP=hypertension. SEP=sepsis. DIR=direct causes. 
IND=indirect causes. Dev=developed regions. N Africa=northern Africa. 
SSA=sub-Saharan Africa. E Asia=eastern Asia. S Asia=southern Asia. 
SE Asia=southeastern Asia. W Asia=western Asia. CC Asia=Caucasus and central 
Asia. LAC=Latin America and the Caribbean.
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and programmes, because interventions to address them 
are very diﬀ erent. Although the international community 
has rightly focused on postpartum haemorrhage, and 
speciﬁ cally atonic postpartum haemorrhage, it is now the 
appropriate time to unpack the obstetric haemorrhage 
category. The improved method used in this analysis 
allowed delineation of haemorrhage deaths, reporting that 
about 24·0% of all haemorrhage deaths happened during 
pregnancy, and the remainder in the intrapartum or 
postpartum period. Thus we provide for the ﬁ rst time an 
evidence-based estimation of the proportion of maternal 
deaths due to antepartum haemorrhage.
Also alarming is the proportion of deaths attributed to 
hypertensive disorders, which are the second highest 
 Panel: Misclassiﬁ cation and underreporting issues by cause of death
Abortion
We estimated that 7·9% (95% UI 4·7–13·2) of all maternal deaths were due to 
abortion. This ﬁ nding is lower than the previous assessments, which estimated 
mortality due to unsafe abortion at 13%.19,20 Classiﬁ cation of maternal deaths 
due to abortion, and more speciﬁ cally unsafe abortion, is associated with a risk 
of misclassiﬁ cation, which might lead to underreporting. Even where induced 
abortion is legal, religious and cultural perceptions in many countries mean that 
women do not disclose abortion attempts and relatives or health-care 
professionals do not report deaths as such. Under-registration of deaths might 
be the result of stigmatisation of abortion aﬀ ecting what information is 
reported by relatives and informants or intentional misclassiﬁ cation by 
providers when abortion is restricted.21
In these circumstances, the overall number of maternal mortality might not be 
aﬀ ected, whereas abortion-related deaths might be particularly underestimated 
because of this under-reporting. Although these abortion-related deaths might be 
classiﬁ ed mainly into sepsis and haemorrhage, this might over-simplify the 
complexity of death reporting. An analysis22 comparing International 
Classiﬁ cation of Diseases 10 (ICD-10) codes for underlying cause of death with the 
remainder of information about the death certiﬁ cate and verbal autopsy in rural 
Mexico found that deaths due to second trimester abortion were misclassiﬁ ed 
into both maternal and non-maternal deaths. Examples of misclassiﬁ cation 
included assigning underlying cause of death from amniotic ﬂ uid embolism to 
cerebral anoxia, rather than abortion, either induced or spontaneous. Validation 
studies like this provide needed insight into the quality and accuracy of maternal 
mortality data. However, short of reviewing every death certiﬁ cate and medical 
record after the death of a woman aged 15–49 years, the study further highlights 
the diﬃ  culty associated with considering adjustments to account for this type of 
misclassiﬁ cation, or indeed any misclassiﬁ cation. Validation studies can identify 
patterns of systematic or unbalanced misclassiﬁ cation, but the validity of 
application of adjustment parameters derived by verbal autopsy data from one 
location to another, and application of factors from hospital-based studies to 
population-based data, can be problematic.23
Obstructed labour
Deaths that happen after obstructed labour and its consequences are hard to 
measure because they can be coded as uterine rupture, haemorrhage, or sepsis. 
This is especially problematic in settings where verbal autopsies are used to 
establish cause of death. Verbal autopsy methods do not have consistent case 
deﬁ nitions, which creates confusion regarding hierarchical assignment of 
causes and subsequently aﬀ ects the validity of the study data.24 A speciﬁ c 
mention is warranted to clarify the classiﬁ cation of obstructed labour in this 
study, which is subsumed into direct causes of death, following guidance from 
ICD-MM.14 Although from a clinical perspective, obstructed labour is commonly 
understood as a phenomenon by which a woman might die in labour, from an 
epidemiological and classiﬁ cation standpoint, it is inappropriate to identify 
obstructed labour as a cause of death.
The ICD-10 aims to capture the initiating step most relevant to public health in 
the sequence leading to death, because preventing this disorder would prevent 
not just the death, but all of the illness, complications, and disability that 
preceded it. In these cases of obstructed labour, death might be prevented by 
access to operative delivery. However, when the only available information 
from a lay reporter suggests that the woman seemed to be in labour, or in 
pain, for a long time before death, little is actually known about the sequence 
of events that leads to death, or about the progress of labour. These deaths 
might be misattributed to obstructed labour, leading to overestimation of the 
proportion that could be prevented through operative delivery and 
underestimation of the need for other services. In most settings, the 
implementation of ICD-10 coding does not allow dual coding for cause of 
death—eg, obstructed labour and sepsis, or obstructed labour with uterine 
rupture and haemorrhage. Proposals for the ICD-11 revision link the disorders, 
thereby satisfying the need for clinicians to document obstructed labour while 
ascertaining the cause of death.
Indirect causes of death (excluding HIV/AIDS)
The phenomenon of misattribution of indirect maternal causes of death, 
resulting in underestimation of 20−90% of maternal deaths, has been 
described in a number of settings.25–30 In Austria, misclassiﬁ cation was 
signiﬁ cantly higher for indirect deaths (81%, 95% CI 64−91) than direct 
deaths (28%, 21−36),31 whereas in the UK, indirect deaths accounted for up to 
74% of under-reported maternal deaths during 2003–05.30
HIV/AIDS
Under-reporting and misclassiﬁ cation of indirect maternal deaths due to HIV/
AIDS are especially problematic. Although verbal autopsy might be able to 
measure AIDS mortality,43 hospital data-based validation studies might not be 
useful in adjusting for the eﬀ ect of misclassiﬁ cation error in the estimates of 
cause-speciﬁ c mortality fractions at the population level.23
When deaths happen in a facility, death certiﬁ cate reporting might show 
only HIV as a cause of death and not an obstetric complication such as sepsis. 
This situation highlights the need for speciﬁ c review of deaths of women 
infected with HIV temporal to pregnancy. The woman might die from HIV or 
with HIV while pregnant. Since 2010, this distinction is now possible from 
the standpoint of statistical tabulation as per ICD-10 coding. Our analyses 
precede the changes in ICD-10 coding and so a decision was made to 
consider cases where HIV was listed as a cause of maternal death, whether by 
description or use of a B code, as an indirect maternal death. As these data 
are scarce, the proportion of indirect maternal deaths due to HIV is probably 
underestimated in this study. It is anticipated that as methods for global 
maternal death estimation evolve, evidence of the parameters needed to 
estimate indirect maternal HIV deaths and further clariﬁ cation on the use of 
ICD-10 codes will standardise and improve our understanding of maternal 
and HIV death tallies.14
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worldwide among all direct causes and the most 
prominent cause in the Latin America and Caribbean 
region. This ﬁ nding is despite the well established 
evidence that magnesium sulphate more than halves the 
risk of death from pre-eclampsia.36–39 Although magnesium 
sulphate is deemed an essential drug by WHO,40 the 
problem is the extent to which it is available and 
appropriately used in most countries. A systematic review 
on the prevalence of pre-eclampsia and eclampsia 
described the barriers to the use of magnesium sulphate 
as drug licensing and availability, inadequate and poorly 
implemented clinical guidelines, and insuﬃ  cient political 
support for policy change.41 More recently, a WHO survey 42 
of delivery care in more than 300 health facilities in 
29 countries highlighted that, even if coverage of 
magnesium sulphate is high in cases where coverage is 
needed, the overall mortality due to eclampsia was not 
reduced, highlighting the fact that more attention to other 
elements of quality of care is also needed.
The large proportion of deaths attributed to indirect 
causes cannot be ignored. As direct maternal deaths 
decrease because of targeted interventions, eﬀ orts to 
reduce maternal mortality will have to be refocused on 
reduction of indirect causes. Although emphasis has been 
placed on linking maternal and HIV care, addressing the 
needs of women with pre-existing comorbid disorders 
such as cardiac and endocrine disease in pregnancy will 
need additional links between obstetric and other medical 
specialties. This situation is further complicated as the 
burden of non-communicable diseases is high in 
developing countries where health systems are poorly 
equipped to coordinate specialised care. The four main 
non-communicable diseases are cardiovascular diseases, 
cancers, diabetes, and chronic respiratory diseases.43 
Among these diseases, diabetes, cardiovascular, 
respiratory disorders, and cancers are of particular concern 
among reproductive aged women for their potential 
contribution as indirect causes for both morbidity and 
mortality. Further focus on understanding the true 
burden of these disorders in pregnancy, and on the 
changing demographics of disease patterns, is warranted.
The gaps in coverage of eﬀ ective interventions, for both 
direct and indirect causes of deaths, according to their 
distribution in various settings have large implications in 
view of the urgent need to accelerate the rate of decrease 
in maternal mortality to reach the MDG5 target and 
further to end all preventable maternal deaths.44 Therefore, 
accurate and routine information about causes of maternal 
deaths is crucial in both implementation of interventions 
and tracking and interpretation of the gaps in coverage.
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